PMID- 36449195
OWN - NLM
STAT- MEDLINE
DCOM- 20221202
LR  - 20221202
IS  - 0927-3042 (Print)
IS  - 0927-3042 (Linking)
VI  - 184
DP  - 2022
TI  - Moderna, Pfizer-BioNTech, and Johnson & Johnson/Janssen Post-Covid Vaccine 
      Hematological Adverse Events Including Cerebral Venous Sinus Thrombosis (CVST), 
      Thrombotic Thrombocytopenia (VITT), Blood Clots, Increased Vaginal/Menstrual 
      Bleeding and/or Miscarriage, Stillbirth Delivery, or Premature Birth.
PG  - 151-160
LID - 10.1007/978-3-031-04402-1_11 [doi]
AB  - The Centers for Disease Control (CDC) indicated in 2021 that it would monitor for 
      possible post-COVID-19 vaccination coagulopathy adverse events (AEs).
CI  - (c) 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.
FAU - Champigneulle, Oscar
AU  - Champigneulle O
AD  - SONAR (Southern Network on Adverse Reactions) Program, University of South 
      Carolina College of Pharmacy, Columbia, SC, 29208, USA.
FAU - Bennett, Charles L
AU  - Bennett CL
AD  - SONAR (Southern Network on Adverse Reactions) Program, University of South 
      Carolina College of Pharmacy, Columbia, SC, 29208, USA. bennettc@cop.sc.edu.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Cancer Treat Res
JT  - Cancer treatment and research
JID - 8008541
RN  - 0 (COVID-19 Vaccines)
SB  - IM
MH  - Female
MH  - Pregnancy
MH  - Humans
MH  - *Abortion, Spontaneous
MH  - Stillbirth
MH  - COVID-19 Vaccines/adverse effects
MH  - *Premature Birth
MH  - *COVID-19
MH  - *Thrombocytopenia
MH  - *Thrombosis
MH  - *Sinus Thrombosis, Intracranial/etiology
EDAT- 2022/12/01 06:00
MHDA- 2022/12/03 06:00
CRDT- 2022/11/30 11:21
PHST- 2022/11/30 11:21 [entrez]
PHST- 2022/12/01 06:00 [pubmed]
PHST- 2022/12/03 06:00 [medline]
AID - 10.1007/978-3-031-04402-1_11 [doi]
PST - ppublish
SO  - Cancer Treat Res. 2022;184:151-160. doi: 10.1007/978-3-031-04402-1_11.